ASSOCIATION BETWEEN IN-VIVO IODODEOXYURIDINE LABELING, MIB-1 EXPRESSION, MALIGNANCY GRADE AND CLINICAL STAGE IN HUMAN PROSTATE-CANCER

Citation
M. Borre et al., ASSOCIATION BETWEEN IN-VIVO IODODEOXYURIDINE LABELING, MIB-1 EXPRESSION, MALIGNANCY GRADE AND CLINICAL STAGE IN HUMAN PROSTATE-CANCER, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 106(3), 1998, pp. 389-395
Citations number
26
Categorie Soggetti
Pathology,Microbiology,Immunology
ISSN journal
09034641
Volume
106
Issue
3
Year of publication
1998
Pages
389 - 395
Database
ISI
SICI code
0903-4641(1998)106:3<389:ABIILM>2.0.ZU;2-R
Abstract
Large variability in the biological behavior of prostate cancer makes prognostic markers important. The extent of tumor cell proliferation h as been suggested as an important predictor of clinical outcome. Fifty -five patients suspected of having or with previously diagnosed prosta te cancer were labeled in vivo with IdUrd (a thymidine analogue incorp orated into DNA in S-phase cells) by intravenous infusion before trans urethral resection. IdUrd-labeled cells and MIB-1-positive cells were detected by immunohistochemistry. We found statistically significant a ssociations between the tumor cell proliferation rates measured by in vivo IdUrd labeling and MIB-1 expression in formalin-fixed paraffin-em bedded tumors. Good correlations were also found between S-phase fract ion, MIB-1 expression, clinical stage and malignancy grade. These resu lts make larger retrospective studies on archival tissue meaningful.